Free Trial
Ends Tomorrow! Last Chance to Get MarketBeat All Access at $149
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149
Claim MarketBeat All Access Sale Promotion

Hyperliquid Strategies (NASDAQ:PURR) Stock Sees Heavy Call Option Buying

Hyperliquid Strategies logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • Unusual options activity: Investors purchased 48,921 call options on Hyperliquid Strategies, 56% above the typical volume of 31,429 contracts.
  • Analyst outlook remains positive but mixed: The stock has a consensus “Buy” rating and an average price target of $19.80, although some firms recently downgraded their views to “Hold” or “Sell.”
  • Shares surged amid heavy trading: PURR rose $1.96 to $11.93, with trading volume exceeding 48 million shares—more than four times its average—while institutional investors hold 9.45% of the stock.
  • MarketBeat previews top five stocks to own in November.

Hyperliquid Strategies Inc (NASDAQ:PURR - Get Free Report) saw some unusual options trading activity on Thursday. Stock investors acquired 48,921 call options on the company. This is an increase of 56% compared to the typical volume of 31,429 call options.

Wall Street Analysts Forecast Growth

A number of research firms have commented on PURR. Weiss Ratings lowered shares of Hyperliquid Strategies from a "buy (b-)" rating to a "hold (c+)" rating in a research note on Friday, October 23rd. Chardan Capital boosted their price target on shares of Hyperliquid Strategies from $9.75 to $17.00 and gave the company a "buy" rating in a report on Friday, August 28th. Compass Point began coverage on shares of Hyperliquid Strategies in a research note on Monday, September 14th. They set a "buy" rating and a $18.00 target price on the stock. Cantor Fitzgerald increased their target price on Hyperliquid Strategies from $22.60 to $34.20 and gave the company an "overweight" rating in a report on Thursday, September 10th. Finally, Wall Street Zen lowered Hyperliquid Strategies from a "hold" rating to a "sell" rating in a research report on Sunday, October 11th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Buy" and an average price target of $19.80.

View Our Latest Analysis on Hyperliquid Strategies

Hyperliquid Strategies Price Performance

NASDAQ:PURR traded up $1.96 during trading hours on Thursday, reaching $11.93. The company's stock had a trading volume of 48,080,395 shares, compared to its average volume of 11,885,097. The company has a market cap of $3.32 billion, a price-to-earnings ratio of -1.86 and a beta of 1.89. Hyperliquid Strategies has a one year low of $3.01 and a one year high of $14.76. The business's 50-day moving average is $11.35 and its 200-day moving average is $7.95.

Hedge Funds Weigh In On Hyperliquid Strategies

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. BlackRock Inc. acquired a new stake in shares of Hyperliquid Strategies in the 2nd quarter valued at $79,842,000. Paradigm Operations LP bought a new position in Hyperliquid Strategies during the 2nd quarter valued at about $44,936,535. OLP CAPITAL MANAGEMENT Ltd acquired a new position in Hyperliquid Strategies in the first quarter valued at about $10,459,000. Galaxy Digital Inc. bought a new stake in Hyperliquid Strategies during the first quarter worth about $4,581,000. Finally, Wealth High Governance Capital Ltda acquired a new stake in shares of Hyperliquid Strategies during the second quarter worth approximately $6,517,000. Institutional investors own 9.45% of the company's stock.

Hyperliquid Strategies Company Profile

(Get Free Report)

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Hyperliquid Strategies Right Now?

Before you consider Hyperliquid Strategies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hyperliquid Strategies wasn't on the list.

While Hyperliquid Strategies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines